AHRQ director Clancy to step down later this year

The director of the American Healthcare Research and Quality (AHRQ), Carolyn M. Clancy, MD, is planning to step down later this year after a decade leading the agency., Secretary of the the U.S. Department of Health and Human Services (HHS), Kathleen Sebelius, in a Jan. 31 email to HHS leaders and AHRQ staff, said she was “deeply grateful” for Clancy’s service. “Under Carolyn’s leadership, AHRQ has undertaken innovativ new work that has improved the quality, safety, efficiency, and effectiveness of the nation’s healthcare delivery system,” Sebelius noted. Carolyn has been passionate about the importance of linking quality improvement with the urgency of reducing disparities in healthcare. During her tenure, the agency produced the nation’s first annual reports on quality, safety, and disparities in care. AHRQ has supported groundbreaking researh on patient safety and related interventions, such as TeamSTEPPS, the Comprehensive Unit-based Safety Program, and other efforts to reduce healthcare associated infections, now implemented both nationwide and internationally. Clancy will continue to serve while HHS leaders continue their national search for a new AHRQ director.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup